Bodal Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹863 Cr +79.8% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
BC

Bodal Chemicals Ltd

Q3 FY26Chemicals & Petrochemicals

Bodal Chemicals Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹490Cr
+10.6% YoY
+2.1% QoQ
Net profit
₹0Cr
Q3 FY25: ₹5 Cr
Margin
4.5%
−5.5 pp YoY
−0.3 pp QoQ

Based on Bodal Chemicals Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹195
Market cap₹2.4K Cr
P/E35.1

The short version

Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn). EBITDA (Consolidated, Q3 FY26): Rs. 371.3 million, down 20.0% YoY (Page 10).

From Bodal Chemicals Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn).
  • Standalone revenue for Q3 FY26: Rs. 4,953.1 Mn, up 13.5% YoY (Q3 FY25: Rs. 4,362.1 Mn).
  • Product-wise Q3 FY26 revenue and YoY growth:
  • Dye Intermediates: Rs. 1,826 Mn, +2% YoY quarterly.
  • Dyestuff: Rs. 1,315 Mn, +15% YoY quarterly.
  • Basic Chemicals: Rs. 247 Mn, -15% YoY quarterly (due to annual maintenance shutdown).

2 more points from Bodal Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The presentation mentions a "New greenfield expansion" as part of the company's "Way Forward" strategy (Page 27).
  • This expansion is aligned with capacity ramp-up goals and ongoing internal efficiencies (Page 27).
  • The presentation also refers to capacity ramp-up and strengthening market leadership as priorities.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Bodal Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Bodal Chemicals Ltd Q3 FY26 results — key figures

Bodal Chemicals Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue490443+10.6%480+2.1%
Operating profit (EBITDA)2244-50%23-4.3%
Operating margin4.5%10%-5.5 pp4.8%-0.3 pp
Profit before tax08-100%6-100%
Net profit (PAT)05-100%6-100%
EPS (₹)0.020.43-95.3%0.48-95.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bodal Chemicals Ltd Q3 FY26 results?

Consolidated revenue for Q3 FY26: Rs. 5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. 4,453.7 Mn). EBITDA (Consolidated, Q3 FY26): Rs. 371.3 million, down 20.0% YoY (Page 10).

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

The presentation mentions a "New greenfield expansion" as part of the company's "Way Forward" strategy (Page 27).

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.